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(57)	 ABSTRACT
An assay technique for label-free, highly parallel, qualitative
and quantitative detection of specific cell populations in a
sample and for assessing cell functional status, cell-cell inter-
actions and cellular responses to drugs, environmental toxins,
bacteria, viruses and other factors that may affect cell func-
tion. The technique includes a) creating a first array of binding
regions in a predetermined spatial pattern on a sensor surface
capable of specifically binding the cells to be assayed; b)
creating a second set of binding regions in specific spatial
patterns relative to the first set designed to efficiently capture
potential secreted or released products from cells captured on
the first set of binding regions; c) contacting the sensor sur-
face with the sample, and d) simultaneously monitoring the
optical properties of all the binding regions of the sensor
surface to determine the presence and concentration of spe-
cific cell populations in the sample and their functional status
by detecting released or secreted bioproducts.
17 Claims, 7 Drawing Sheets
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CYTOMETER ON A CHIP
	
	
adding the required spectral channels substantially increase
the complexity, cost, size, power and weight of the instrumen-
	
This application claims the benefit of U.S. Provisional 	 tation. More fundamentally, the number of specific pheno-
Application No. 60/691,951, filed Jun. 17, 2005.	 types that can be analyzed in such a system is limited by the
This invention was made with government support under 5 number of spectral channels available, which is on the order
	
contract NNJ04JA14C awarded by NASA. The government 	 of 10 in current state-of-the-art flow cytometers.
has certain rights to this invention.
SUMMARY OF THE INVENTION
FIELD OF THE INVENTION
10 As an alternative to flow cytometry and to circumvent some
	
The disclosed embodiments relate to an assay technique 	 of the drawbacks and limitations listed above, the disclosed
	
for the determination of phenotype and function of biological 	 embodiments provide a method and system for characteriza-
cells in a sample using an optical biosensor.
	
	 tion of cell phenotype and function without the use of fluo-
rescent or other molecular labels (hereafter "label-free").
BACKGROUND OF THE INVENTION
	
	
15 Another objective is to accomplishthe aforementioned objec-
tive with a relatively simple, inexpensive, small instrument.
	
Optical techniques that measure cellular phenotype and 	 Yet another objective is to simultaneously perform measure-
	
function most often employ labeled antibodies that specifi- 	 ments on a large number of unique cell interactions for par-
	
cally label proteins of interest. For example, immunohis- 	 allel detection of a plurality of phenotypes and cell functional
tochemistry employs samples that have been affixed to a slide 20 responses in a given sample.
	
and labeled with fluorescently or enzymatically labeled anti-	 Specific capture ligands for specific cell surface markers of
	
bodies. Immunohistochemistry has been used in many con- 	 interest are immobilized on a biosensor surface (a biosensor
	
texts, including the upregulation of proteins and the charac- 	 chip) at discrete locations in a predetermined spatial pattern.
	
terization of cellular phenotypes. Immunofluorescence	 These discrete locations on the chip will be referred to as
microscopy measures antigenic structure with fluorescently 25 cell-capture regions of interest or "cell ROI"s). Binding of
	
labeled antibodies. Uses of this technique include studies of	 cells to the capture ligands in a cell ROI locally changes some
	
surface expression of proteins in normal and leukemic lym- 	 measurable properties of the cell ROI and this change is
	
phocytes, and surface protein internalization by activated 	 measured with a suitable detection system. The presence of
	
cells. In confocal microscopy, a laser is scanned across cells 	 cells in a sample expressing a particular surface phenotype is
labeled with fluorescent antibodies. The specimen is brought 30 detected by bringing the sample into contact with the biosen-
	
into focus by an objective lens and laterally scanned under 	 sor chip surface and measuring the measureable signals from
	
computer control. Cross-sectional areas are computationally 	 cell ROIs containing the cognate capture ligand. Including an
	
compiled into three-dimensional objects and the subcellular 	 array of cell ROIs containing specific capture ligands to dis-
	
location of labeled proteins is then determined. Confocal 	 tinct surface markers provides for the simultaneous detection
microscopy has been used to study antigen expression, apo- 35 of a plurality of phenotypes, the identities of which are spa-
ptosis, and cellular activation. 	 tially encoded on the chip. That is, a given phenotype is
	
One of the most common technologies used to phenotype 	 correlated to a particular address (location) on the chip. A
	
cells is flow cytometry. Flow cytometry measures light scat- 	 biosensor chip with hundreds or more ROIs provides for
	
tering, impedance, and fluorescent signals to characterize 	 highly parallel detection of many cell phenotypes in a given
specific cell types and can identify subpopulations of these 40 sample.
	
cells for sorting. Commercially available flow cytometers	 Specific capture ligands that may be employed include, but
	
measure up to eight different fluorescent molecules bound to 	 are not limited to antibodies, aptamers, specific receptors,
	
a cell, each emitting a distinct wavelength of fluorescent light. 	 MHC-peptide complexes, oligonucleotides, and peptide
	
Flow cytometers also can measure cellular processes such as 	 nucleic acid oligomers. The disclosed embodiments also pro-
cell division, apoptosis, necrosis, and differentiation. Recent 45 vide for use of non-specific capture ligands to assess the
	
developments in flow cytometry sort analyzed cells into	 behavior of mixed cell populations. Examples of non-specific
	
microchannels and separate these populations according to	 capture ligands include, but are not limited to antibodies
fluorescence characteristics. 	 against species-specific antigens and anti-MHC antibodies.
	
Flow cytometry has a number of limitations. One drawback
	 Measuring the binding of cells to a cell ROI is accom-
is that flow cytometry requires pre-labeling of the cells with 50 plished by measuring the localized measurable response of
	
fluorescent antibodies or other fluorophores and entails com- 	 each cell ROI, preferably with a system that permits parallel
	
plex experimental protocols that may be difficult to imple- 	 measurement from all ROIs. Examples of biosensor surfaces
	
ment in many environments (e.g., resource-poor settings). 	 include a metal-coated optical grating, which upon illumina-
	
For flow cytometry to be accurate, the cells must be precisely 	 tion by light of the appropriate wavelength and polarization
moved through the center of the focal plane of the illuminat- 55 couples incident light into surface plasmons onthe metal at an
	
ing light. This requires a sophisticated system of fluidics, and	 appropriate angle of incidence (resonant condition), which is
	
a narrow orifice in the flow cell (usually in the 50 to 100	 related to the number of cells bound to the ROI. Other appli-
	
micron diameter range). Disturbances in the sample stream 	 cable biosensing approaches are well known in the art and
	
can alter the information produced by a flow cytometer, mak- 	 include planar waveguide devices, resonant mirrors, guided-
ing this technology sensitive to sample clogging and to envi- 60 mode resonant filters and resonant acoustic devices.
	
ronmental perturbations. Distinguishing the various cell phe- 	 In addition to spatially sorting cells based on cell pheno-
	
notypes in a sample requires excitation at multiple 	 type, another objective is to measure cellular responses in real
	
wavelengths and monitoring of the fluorescence signal in	 time or near real time without the use of molecular labels.
	
multiple spectral bands. This requires a multi-wavelength 	 Cells respond to environmental stimuli in a variety of ways
laser system and multichannel detection, which results in the 65 (e.g., altering shape, secreting bioproducts, such as cytokines,
	
need for complex compensation and dramatically increases 	 lysing, undergoing programmed cell death, etc). The dis-
	
the number of controls. As multiplexing capacity is increased, 	 closed embodiments provide for detection of cellular
US 7,655,421 B2
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responses to stimuli by including on the biosensor surface sets
of secondary ROIs containing capture ligands to specific cell
bioproducts. These "response ROIs" (to be distinguished
from cell ROIs) are strategically placed in close proximity to
and in predetermined spatial patterns relative to cell ROIs and
may overlap the cell ROIs. The shape, location and pattern of
cell ROIs and response ROIs are designed to generate spatial
and temporal optical signatures which provide information
on cell phenotype and function (e.g., secretion of cytokines),
in near real time in a highly multiplexed label-free manner.
Since a biosensor chip can accommodate hundreds or more
ROIs, the disclosed embodiments provide for highly parallel
detection of many cell phenotypes and associated functional
responses in a given sample.
Types of cells that can be analyzed with the disclosed
embodiments include, but are not limited to, mammalian
cells, plant cells and bacteria. Applications are broad and
encompass many fields such as biodefense, clinical diagnos-
tics, environmental toxicology and drug discovery research.
Some examples of specific applications include bioassays to
detect the presence of toxic or activating compounds, assess-
ment of responses to pharmaceutical drugs, assessment of
host/pathogen interactions and assessment of immune func-
tion. Assays may be conducted in small volumes, on the order
of 10 microliters, enabling minimally invasive diagnostic
tests from samples obtained, for example, by finger stick
using a medical lancet as is routinely done by diabetics when
monitoring blood glucose.
BRIEF DESCRIPTION OF THE DRAWINGS
FIG.1 illustrates in diagrammatic form an embodiment of
an apparatus for measuring cell phenotype and cellular
responses with  surface plasmon resonance optical measure-
ment system;
FIG. 2 shows in schematic form a configuration for the
deposition of capture ligand regions on a biosensor chip;
FIG. 3 shows in schematic form a second configuration for
the deposition of capture ligand regions on a biosensor chip;
FIG. 4 shows in schematic form a third configuration for
the deposition of capture ligand regions on a biosensor chip;
FIG. 5 shows in schematic form a fourth configuration for
the deposition of capture ligand regions on a biosensor chip;
FIG. 6 shows in schematic form a fifth configuration for the
deposition of capture ligand regions on a biosensor chip;
FIG. 7 includes top and side views of a second apparatus
for measuring cell phenotype and measuring cellular
responses including changes in cell shape;
FIG. 8 is a bar graph showing capture and label-free detec-
tion of phenotypic-specific cells in a sample according to the
present invention;
FIG. 9 shows a bar graph demonstrating real time, label-
free detection of phenotypic-specific cells according to this
invention and a set of images showing the number of captured
cells on the biosensor chip;
FIG. 10 is a graph plotting measured SPR angle shift value
against the number of observed cells on a region of interest
(ROI) on the biosensor chip to illustrate quantitative measure-
ment of cell capture according to the invention; and
FIG. 11 is a bar graph showing SPR angle shift at three
different regions of interest (ROIs) on a biosensor chip to
4
illustrate quantitative, real time, label-free measurement of
cytokine secretion by cultured cells.
DESCRIPTION OF THE DISCLOSED
5	 EMBODIMENTS
The following examples are given to illustrate various
embodiments and aspects of the invention and are not
10 intended to limit the claims in any manner whatsoever.
FIG. 1 illustrates an apparatus for measuring cell pheno-
type and cellular responses including a biosensor chip 1 onto
which the cell ROIs 2 and the Response ROIs 4 are deposited
in predetermined spatial patterns. A flow cell 6 that contains
15 the biosensor chip 1, brings a sample into contact with the
biosensor surface, provides a chamber for incubating cells
during the course of an experiment, and provides a window 8
for optical interrogation. An optical detection system pro-
vides an illumination beam 10 and detects the reflected light
20 12 from the chip to measure the binding of cells and bioprod-
ucts to their cognate ROIs. One method of optical interroga-
tion of analyte (cell orbioproduct) binding to the chip is based
on the phenomenon of surface plasmon resonance (SPR). An
25 SPR chip typically includes a reflection-type metallic grating
to couple an incident light beam with surface plasmons in the
metal. This coupling approach makes it possible to directly
illuminate the sensor surface through the sample, which
allows imaging of the entire chip and thus simultaneous mea-
30 surement of hundreds of interactions at the chip surface. In a
preferred embodiment the transducer chip is a gold-coated
plastic (polycarbonate) grating with a grating period of
approximately 600 to 900 microns and a groove depth of
approximately 50 to 80 nin. Illumination is provided by a
35 single light-emitting diode (LED) with peak emission in the
range of 650 to 900 nm and detection is provided by an
imaging device such as a CCD or CMOS camera.
The principle of operation is as follows. For collimated,
monochromatic, p-polarized light incident on the chip at
4o angle 0, through a dielectric medium of refractive index n, the
x-component (the x-axis is along the gold surface and in the
direction perpendicular to the grating grooves) of the light-
wave vector, kmx associated with m-th order diffracted light is
45 
given by:
w	 (1)k„ _ —nsinO+mkg
C
50
where co is the angular optical frequency, c the speed of light
in vacuum, and kg denotes the grating wave vector, which is
along the x-direction (kg-27c/A, where A is the grating
period). The wave vector of the surface plasmons is given by:
55
m	 smn	 (2)
k° c sm+n2
60
where Em is the dielectric constant of the gold and n is the
index of refraction of the adjacent dielectric layer (sample).
At the incident angle, 0 R , for which resonance occurs, kmx, the
65 x-component of the wave vector associated with the dif-
fracted wave of the exciting light must be equal to the wave
vector of the surface plasmon. That is:
US 7,655,421 B2
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m	 m re n3)
—nsinOR +mk
c	 sc+	 (
As Eq. (3) shows, for a given grating design and diffraction
order, the SPR angle, 0,, is very sensitive to variation of the
refractive index of the dielectric adjacent to the gold layer
supporting the surface plasmon wave. The energy of the
excited surface plasmons is taken from incident light causing
the intensity of the zeroth order diffracted beam to decrease.
The grating period A is designed such that for the optical
wavelength used, resonance can be achieved at a relatively
small angle of incidence (near normal to the chip) to facilitate
imaging of the entire chip.
This embodiment provides for measurement of multiple
specific binding events in parallel. For example, antibodies
with the desired specificity are spotted on the gold-coated
sensor chip in a microarray format to form ROIs. Interrogat-
ing light is directed onto the chip surface at a series of incident
angles and the zeroth order diffracted light (specular reflec-
tion) intensity is quantitatively imaged onto a CCD camera at
each angle of incidence. The reflected intensity from each
ROI is a function of the incoming light's incident angle, the
local index of refraction at the surface, and the amount of
analyte bound. The SPR angle (incident illumination angle at
which the reflected light is at a minimum) changes locally at
each ROI as the mass of analyte bound to the ROI changes.
The acquired images are processed in software to deter-
mine the SPR angles for all ROIs on the chip and the process
is repeated through the duration of a measurement cycle to
provide a time course of analyte binding (binding kinetics) to
each ROI. Specific binding events between cellular surface
antigens and immobilized ligands or between secreted bio-
products and their cognate ligands are detected by a shift in
the SPR angle at the respective ROIs.
An illustration of a basic ROI design according to a first
embodiment is shown in FIG. 2. This figure illustrates a single
ROI which functions as both a cell ROI and a Response ROI
since capture ligands for both cells and bioproducts are co-
mingled on a single overlapping spot on the chip. FIG. 2
schematically shows the gold-coated plastic grating chip sub-
strate 14, the optical window 8 above the chip which provides
optical access for measurements and defines the upper flow
cell boundary, and a circular ROI 2 which contains immobi-
lized bioproduct capture antibody 16 and cell capture anti-
body 18. For illustration purposes, FIGS. 2 to 6 show only one
cell capture antibody 18, one captured cell 20 and two anti-
bioproduct antibodies 16 at the ROI 2. In practice the ROIs
would contain a large number of each type of antibody and
one or more cells would be typically captured. In the configu-
ration of FIG. 2, cells are captured by immobilized antibody
against surface determinants and cultured on the chip surface.
As the captured, cultured cells 20 secrete or release proteins
or other macromolecules, those molecules are captured by the
corresponding cognate antibodies 16 intermixed with the cell
capture antibodies 18 in the same ROI 2. Initial changes in
optical or sensing properties at the ROI when sample is first
flowed over the chip reflect the capture of cells of the appro-
priate surface phenotype. Unbound cells are then washed
from the flow compartment (chamber). Subsequent intensity
changes at the ROI during incubation of the captured cells
reflect levels of secreted or released molecules or changes in
cellular phenotype. Another measure of secretion levels could
be assessed by measurement of the distances from the source
cell at which SPR shifts can be measured.
6
An alternative configuration is illustrated in FIG. 3. In this
configuration, cells 20 are captured on a central cell ROI 22
by immobilized antibody 18 against cell surface determinants
and cultured on the chip surface. As the captured cells 20
5 secrete or release proteins or other macromolecules, some of
those molecules are captured by a first set of bioproduct
capture antibodies 16 deposited on a first surrounding circular
response ROI 24 concentric with the central cell ROI 22.
Another set of released or secreted macromolecules is cap-
10 tured by a second set of bioproduct capture antibodies 16a
immobilized on a second concentric circular response ROI 26
of larger diameter. In this configuration, distinct, multiple
secreted protein responses may be simultaneously character-
15 ized.
A further alternative configuration is shown in FIG. 4. In
this configuration, multiple sets of interacting ROIs are cre-
ated. In each set, two cell ROIs 2 and 2a, with their corre-
sponding response ROIs 16 and 16a are placed in proximity
20 to enable the study of cell-cell interactions. A primary
responding cell population 20 is captured by immobilized
antibody 18 against cell surface determinants on a primary
cell ROI 2 and cultured on the chip surface. A secondary cell
ROI 2a captures a second type of cell 20a with antibodies to
25 secondary-cell-specific surface determinants 18a. As the pri-
mary cells 20 secrete or release a first set of proteins or other
macromolecules, some of these molecules are captured by
antibodies 16 immobilized on an adjacent downstream
so response ROI 28. Secondary cells 20a captured in ROI 2a that
are responsive to some of the soluble molecules secreted by
the primary cells 20 may produce a secondary response by
secreting or releasing a second set of protein or other macro-
molecules, some of which may be captured by a second
35 downstream response ROI 28a. Measurements of the inten-
sities, spatial distribution, and temporal responses of SPR
signals from the primary 28 and secondary 28a bioproduct
ROIs provide functional information on both primary and
secondary cells 20, 20a and their interaction. Although FIG.
40 4 illustrates only one set of interacting ROIs it should be clear
that a biosensor chip will generally contain a large array of
such sets, permitting the parallel characterization of multiple
functional responses and cell-cell interactions.
A further alternative ROI configuration is illustrated in
45 FIG. 5. In this configuration a primary cell population 20 is
captured on a cell ROI 2 by immobilized antibody 18 against
cell surface determinants and cultured on the chip surface. As
the captured cells 20 secrete or release enzymes, those pro-
teins are detected by the effect they have on a substrate 3 0 that
50 is localized downstream of the captured cells. An example of
a substrate would be a biomolecules with a moiety that is
cleaved by the released enzyme leading to a change in SPR
signal.
FIG. 6 illustrates a still further alternative ROI configura-
55 tion. In this configuration, the responding cell population 20
is captured by immobilized antibody 18 against cell surface
determinants and cultured on the chip surface. As the cap-
tured cells 20 secrete or release proteins or other macromol-
ecules, those molecules are detected by the surrounding
6o response ROIs 32, 32a, 32b. Each of the surrounding
response ROIs is populated with antibodies 16, 16a, 16b
against a different target, so intensity and spatial signal dis-
tribution provides information on identity and concentration
of the respective secreted products. Changes of the ROI prop-
65 erties with respect to time may provide additional informa-
tion on the dynamics of the cellular responses. In a grating
coupled surface plasmon resonance chip, the intensity of the
US 7,655,421 B2
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reflected light will vary according to changes in the optical
properties of the chip surface at the ROIs due to capture of
cells or cell products.
FIG. 7 (top view) illustrates one possible configuration for
detection of cell shape changes in addition to detection of
secreted or released bioproducts. In this configuration a cell
capture ROI (3) of sufficiently small dimensions to capture
only a single cell is surrounded by a proximal set of shape
sensing ROIs (2) that do not contain capture ligands, and by a
second distal set of response ROIs (1) containing immobi-
lized capture ligand to target analytes that may be secreted or
released by the cell captured in the cell ROI (3). FIG. 7 (side
view) illustrates the mechanism for detection of a cell shape
change: when a rounded cell is captured on the cell ROI (3)
(upper left panel), the optical signal from this ROI changes
accordingly (illustrated in the upper right panel as an increase
in SPR angle according to one possible sensor embodiment)
but the signals from the adjacent shape sensing ROIs (2)
remain at baseline level. A change in cell phenotype to a
flattened shape (lower panel) whereby portions of the cell
overlap the shape sensing ROIs (2) leads to an increase in
optical signal at these ROIs, as illustrated in the lower right
panel.
FIG. 8 illustrates detection of the capture of cells in a
sample based on the expression of specific cell surface mark-
ers. The human cell line 7urkat T cells, which express the
surface marker CD3E were passed across ROIs containing
immobilized anti-human CD3E monoclonal antibodies and
negative control antibodies that bind proteins not present on
7urkat T cells. As evidenced by the observed SPR angle shifts,
7urkat T cells were only captured by the anti-human CD3E
monoclonal antibody ROIs. FIG. 9 shows that the signals
from these ROIs exhibit a time-dependent increase over the
duration of 7urkat T cell flow across the chip reflecting
increasing capture of cells with time. Images of the chip also
show a time-dependent increase in the capture of cells at the
specific cell capture ROIs but do not show cell capture at
irrelevant ROIs (FIG. 9).
Measurements shown in FIG. 10 demonstrate that there is
a linear relationship between the number of captured cells at
an ROI and the measured SPR angle shift. EL4 is a mouse T
cell lymphoma that can be captured by immobilized anti-
mouse CD3E monoclonal antibody. FIG. 10 shows an experi-
ment in which mouse T cell lymphoma cells EL4 were flowed
across a chip containing anti-mouse CD3E antibody capture
ROIs. Each cell captured caused an SPR angle shift of
approximately I millidegree. The data presented in FIG. 10
show that there is a direct correlation between SPR angle shift
and the number of cells captured.
The data presented in FIG. 11 show the capability for
label-free measurement of cell responses in near real time. In
this experiment, activated 7urkat T cells were incubated on
the chip surface, and response (ROIs) comprised of anti-
cytokine (IL-2 and IL-4) and anti-immunoglobulin antibod-
ies were interrogated over time. The production of IL-2 and
IL-4 cytokine was detectable above background after only 20
minutes of assessment. As expected, the signal from the anti-
IgG ROIs did not change significantly from background lev-
els.
What is claimed is:
1. A method for detecting in an aqueous sample a plurality
of cell populations each expressing at least one distinct cell
surface marker and for assessing the functional status of said
cell populations, said method comprising the steps of:
i. providing a sensor surface having optical properties that
change in response to binding of material to the surface
or to molecular adlayers on the surface;
8
ii. creating one or more cell capture regions on said sensor
surface by immobilizing cell capture ligands specific to
said cell surface markers in a predetermined spatial pat-
tern;
5 iii. creating one or more cell product capture regions on
said sensor surface by immobilizing cell product capture
ligands, each said cell product capture ligand being spe-
cific to a secreted or released product from said cell
populations, said one or more cell product capture
10 regions arranged in predetermined spatial patterns
proximal to or overlapping one or more of said cell
capture regions;
iv. contacting said sensor surface with the aqueous sample
containing living cells, cells expressing a cell surface
15 marker specific to said cell capture ligands being cap-
tured at said cell capture regions, captured cells forming
a pattern corresponding to the predetermined spatial
pattern of said one or more cell capture regions;
v. detecting changes in said optical properties at each of
20 said cell capture regions, the magnitude of the detected
change at each cell capture region being a function of the
number of cells captured at said each cell capture region;
vi. replacing the aqueous sample with a biological buffer
comprising a culture medium and incubating the cap-
25 tured cells on said sensor surface, cell products secreted
or released from said captured cells being captured at
cell product capture regions having a cell product cap-
ture ligand specific to said cell products, captured cell
products forming a pattern corresponding to the prede-
30	 termined spatial patterns of said one or more cell product
capture regions;
vii. monitoring changes in said optical properties at each of
said cell product capture regions over time, the magni-
tude of the change in optical properties at each said cell
35 product capture region being a function of the quantity
of the secreted or released product from said captured
cells captured at each of said cell product capture
regions; and
viii. using the detected changes of the optical properties of
40 the sensor surface at said cell capture regions and said
cell product capture regions to provide information on
cell functions of said captured cells over time.
2. The method of claim 1, wherein said step of providing a
sensor surface comprises:
45 providing a grating coupled surface plasmon resonance
chip having a sensor surface wherein said optical prop-
erties are a refractive index.
3. The method of claim 2, wherein said step of detecting
50 
changes in said refractive index comprises:
illuminating the sensor surface with light of a substantially
constant wavelength at a plurality of incident angles; and
measuring an intensity of the zeroth order diffracted light at
each angle of incidence from each of said cell capture
55	 regions and cell product capture regions.
4. The method of claim 1, wherein the sensor surface is
based on evanescent waveguide sensing.
5. The method of claim 1, wherein the step of contacting
the sensor surface with the aqueous sample is performed for
60 a predetermined period of time.
6. The method of claim 1, wherein the step of creating one
or more cell capture regions on said sensor surface comprises:
creating a plurality of cell capture regions, said plurality of
cell capture regions including first cell capture regions
65 having first cell capture ligands specific to cell surface
markers for capturing a first cell population and second
cell capture regions having second cell capture ligands
US 7,655,421 B2
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specific to cell surface markers for capturing a second
cell population distinct from said first cell population.
7. The method of claim 6, wherein said step of creating a
plurality of cell capture regions comprises:
arranging said first and second cell capture regions in pre-
determined spatial patterns, whereby each of said first
and second cell populations are correlated to a known
location on said sensor surface.
8. The method of claim 6, comprising the steps of:
selecting said first and second cell populations wherein
said second cell population responds to a first secreted or
released cell product from said first cell population by
secreting or releasing a second cell product;
wherein said step of creating one or more cell product
capture region comprises:
creating at least one cell product capture region in proxim-
ity to or overlapping one or more of said second cell
capture regions, said at least one cell product capture
region including a cell product capture ligand specific to
said second cell product; and
said step of using the detected changes of the optical prop-
erties at said cell capture regions and said cell product
capture regions provides information on the function of
said first and second cell populations and their interac-
tion.
9. The method of claim 6, comprising the steps of:
positioning said sensor surface in a flow cell which defines
a flow path for said aqueous sample and said biological
buffer and a chamber for incubating the captured cells,
said flow cell also including a window permitting optical
interrogation of said sensor surface;
said step of creating one or more cell product capture
regions comprises:
locating at least one of said one or more cell product cap-
ture regions so that said aqueous sample or said biologi-
cal buffer contacts at least one of said one or more cell
capture regions before contacting said at least one cell
product capture region.
10. The method of claim 1, wherein the step of contacting
the sensor surface with the aqueous sample is performed for
a predetermined period of time and the detected change in
optical properties at each of said cell capture regions is used
to calculate the concentration of cells having the cell surface
marker at each said cell capture region in said aqueous
sample.
11. The method of claim 1, wherein the step of creating one
or more second capture regions comprises:
creating a plurality of cell product capture regions proxi-
mal to at least one cell capture region, at least one of said
plurality of said cell product capture regions including a
cell product capture ligand different from a cell product
capture ligand of another of said plurality of cell product
capture regions.
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12. The method of claim 11, wherein said method com-
prises;
detecting changes in said optical properties at each of said
plurality of cell product capture regions over time,
s whereby the presence and concentration of different
secreted or released cell products are measured with
respect to time.
13. The method of claim 1, wherein said step of creating
one or more cell capture regions comprises:
10	 creating at least one cell capture region configured to cap-
ture a single cell.
14. The method of claim 1, wherein said method com-
prises:
detecting changes in said optical properties of said sensor
15 surface in proximity to at least one of said cell capture
regions over time, whereby changes in the shape of one
or more cells captured on said at least one cell capture
region are measured with respect to time.
15. The method of claim 1, wherein said step of creating
20 one or more cell product capture regions comprises:
creating at least one cell product capture region overlap-
ping with at least one of said cell capture regions, said
cell capture ligands of said at least one cell capture
region and said cell product capture ligands being inter-
25	 mingled in a single overlapping region on said sensor
surface.
16. The method of claim 15, wherein said step of detecting
changes in said optical properties of said cell capture regions
comprises:
30	 detecting changes in the optical properties of said single
overlapping region before said step of replacing the
aqueous sample with a biological buffer and incubating
the captured cells, said changes being a function of the
number of cells captured at said single overlapping
35	 region; and
detecting changes in the optical properties of said single
overlapping region during incubation of said captured
cells, said changes in the optical properties of said single
overlapping region during incubation being a function of
40 at least one of the quantity of secreted or released cell
products captured at said single overlapping region and
changes in cell shape.
17. The method of claim 1, comprising the step of:
exposing the cells captured at one or more of said cell
45	 capture regions to a stimuli;
detecting changes in the optical properties of said cell
capture regions and said cell product capture regions;
and
using the detected changes in said optical properties at said
50	 cell capture regions and said cell product capture regions
to provide information on the response of said captured
cells to said stimuli.
